{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:43:54Z","timestamp":1761857034202,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.pathol.2021.01.018","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:53:32Z","timestamp":1620946412000},"page":"883-888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lack of standardisation in interpretation and reporting of autoantibody assays: a survey analysis of Australasian laboratories with focus on line immunoassays"],"prefix":"10.1016","volume":"53","author":[{"given":"Matthew","family":"Krummenacher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Wienholt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravin","family":"Hissaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2021.01.018_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0961203313515763","article-title":"A\u00a0surge in anti-dsDNA titer predicts a severe lupus flare within six months","volume":"23","author":"Pan","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.pathol.2021.01.018_bib2","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/rheumatology\/kem112","article-title":"Fifty years of anti-ds DNA antibodies: are we approaching journey's end?","volume":"46","author":"Isenberg","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.pathol.2021.01.018_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2013-203863","article-title":"International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","volume":"73","author":"Agmon-Levin","year":"2014","journal-title":"Ann Rheum Dis"},{"year":"2020","series-title":"Pathogenesis of Hashimoto's thyroiditis (chronic autoimmune thyroiditis)","author":"UpToDate","key":"10.1016\/j.pathol.2021.01.018_bib4"},{"key":"10.1016\/j.pathol.2021.01.018_bib5","series-title":"Autoantibodies in Organ Specific Autoimmune Disease: A Diagnostic Reference","first-page":"8","author":"Conrad","year":"2011"},{"key":"10.1016\/j.pathol.2021.01.018_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.autrev.2009.01.013","article-title":"Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory","volume":"8","author":"Bossuyt","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.pathol.2021.01.018_bib7","first-page":"1","article-title":"Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","volume":"2014","author":"Mahler","year":"2014","journal-title":"J\u00a0Immunol Res"},{"key":"10.1016\/j.pathol.2021.01.018_bib8","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1136\/annrheumdis-2016-211039","article-title":"Anticitrullinated protein antibodies: taking into account antibody levels improves interpretation","volume":"76","author":"Bossuyt","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.pathol.2021.01.018_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/ard.2007.085597","article-title":"Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor","volume":"68","author":"Bossuyt","year":"2009","journal-title":"Ann Rheum Dis"},{"year":"2018","series-title":"EUROLINE ANA profile 3 plus DFS70 (IgG) test instruction [package insert]. Version: 20\/03\/2018","author":"Euroimmun","key":"10.1016\/j.pathol.2021.01.018_bib10"},{"key":"10.1016\/j.pathol.2021.01.018_bib11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pathol.2016.03.012","article-title":"Diagnostic performance of a commercial immunoblot assay for myositis antibody testing","volume":"48","author":"Bundell","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2021.01.018_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/08916934.2018.1441830","article-title":"Clinical contribution of myositis-related antibodies detected by immunoblot to idiopathic inflammatory myositis: a one-year retrospective study","volume":"51","author":"Lecouffe-Desprets","year":"2018","journal-title":"Autoimmunity"},{"key":"10.1016\/j.pathol.2021.01.018_bib13","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/1756-185X.12792","article-title":"TEST performance of a myositis panel in a clinical immunology laboratory in New South Wales, Australia","volume":"19","author":"Tan","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.pathol.2021.01.018_bib14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.41088","article-title":"Myositis autoantibodies: a comparison of results from the Oklahoma medical research foundation myositis panel to the Euroimmun research line blot","volume":"72","author":"Mecoli","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.pathol.2021.01.018_bib15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fimmu.2015.00194","article-title":"Strategies for building reference standards for autoantibodies","volume":"6","author":"Sheldon","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.pathol.2021.01.018_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0004563214551066","article-title":"Uncertainty of measurement: an immunology laboratory perspective","volume":"52","author":"Beck","year":"2015","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.pathol.2021.01.018_bib17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fmed.2018.00088","article-title":"Recognition and relevance of anti-DFS70 autoantibodies in routine antinuclear autoantibodies testing at a community hospital","volume":"5","author":"Carter","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.pathol.2021.01.018_bib18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12016-016-8564-5","article-title":"The clinical relevance of anti-DFS70 autoantibodies","volume":"52","author":"Conrad","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.pathol.2021.01.018_bib19","first-page":"69","article-title":"Revisiting the antinuclear antibody test with emphasis on a new pattern: anti-DFS70 antibody","volume":"210","author":"Hissaria","year":"2019","journal-title":"MJA"},{"key":"10.1016\/j.pathol.2021.01.018_bib20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3899\/jrheum.140677","article-title":"Four anti-dsDNA antibody assays in relation to systemic lupus erythematosus disease specificity and activity","volume":"42","author":"Enocsson","year":"2015","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.pathol.2021.01.018_bib21","first-page":"675","article-title":"Evaluation of Anti-dsDNA antibody tests: crithidia luciliae immunofluorescence test, immunoblot, enzyme-linked immunosorbent assay, chemiluminescence immunoassay. (Korean)","volume":"30","author":"Yang","year":"2010","journal-title":"Kor J Lab Med"},{"key":"10.1016\/j.pathol.2021.01.018_bib22","first-page":"353","article-title":"Detection of anti-ENA and anti-dsDNA antibodies using line immunoassay in systemic autoimmune diseases (Korean)","volume":"28","author":"Kim","year":"2008","journal-title":"Kor J Lab Med"},{"key":"10.1016\/j.pathol.2021.01.018_bib23","article-title":"Determination of specific autoantibodies in patients with systemic lupus erythematosus by Line immunoassay, ELISA and CLIF assay","author":"Wongjarit","year":"2020","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.pathol.2021.01.018_bib24","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521001033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521001033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:28:44Z","timestamp":1758472124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302521001033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0031302521001033"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2021.01.018","relation":{},"ISSN":["0031-3025"],"issn-type":[{"type":"print","value":"0031-3025"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of standardisation in interpretation and reporting of autoantibody assays: a survey analysis of Australasian laboratories with focus on line immunoassays","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2021.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}